Results

Total Results: 430 records

Showing results for "cardiac".
Users also searched for: ekg

301. Making Healthcare Safer IV: Summary of Findings on Patient Safety Practices and Ratings by a Technical Expert Panel, 2024-2025 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-iv-patient-safety-practices-year-2.pdf
     May 01, 2025 - confirms the moderate evidence suggesting continuous monitoring's benefit in reducing hospital mortality, cardiac

302. App-D-Surv-Report-1-Noninvasive-Nonpharma 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
     January 01, 2021 - knee and/or hip prosthesis, contraindication to electrotherapy or phototherapy (e.g., uncontrolled cardiac … spinal infection and other medicolegal issues; (d) with contraindications for acupuncture, including cardiac

303. App-D-Surv-Report-2-Noninvasive-Nonpharma (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
     January 01, 2021 - knee and/or hip prosthesis, contraindication to electrotherapy or phototherapy (e.g., uncontrolled cardiac … spinal infection and other medicolegal issues; (d) with contraindications for acupuncture, including cardiac

304. Impact of Healthcare Worker Safety and Wellness: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/worker-safety-wellness-protocol.pdf
     October 26, 2024 - Cancer risk from professional exposure in staff working in cardiac catheterization laboratory: insights

305. Restless-Legs Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
     November 01, 2012 - FDA approved for treatment of RLS and is rarely used in the United States due to FDA warnings about cardiac … of RLS and is rarely used in the United States due in part to FDA warnings about increased risk of cardiac

306. Stroke-Atrial-Fibrillation Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_executive.pdf
     August 01, 2013 - uncoordinated atrial activation with consequent deterioration of mechanical function.1 AF is the most common cardiac … arrhythmia in clinical practice, accounting for approximately one-third of hospitalizations for cardiac

307. Ced-Topic-Refinement (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced-topic-refinement.pdf
     November 01, 2022 - carotid artery stenting, implantable cardioverter defibrillator (ICD) for primary prevention of sudden cardiac … death, and magnetic resonance angiography/magnetic resonance imaging in patients with a cardiac implantable

308. Vitamin D and Calcium: A Systematic Review of Health Outcomes (Update) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_executive.pdf
     September 01, 2014 - associations were found for three outcomes, suggesting increased risk with supplementation for a composite cardiac … outcome, invasive cardiac interventions, and transient ischemic attacks. … No significant associations were found for a composite cardiac outcome, coronary heart disease death

309. Methods White Paper: Improving the Utility of Evidence Synthesis for Decision Makers in the Face of Insufficient Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/improving-utility-evidence-synthesis-white-paper.pdf
     April 01, 2021 - using different instruments in different patient populations with inconsistent results Use of Cardiac … Use of Cardiac Resynchronization Therapy.

310. Executive Summary: Pain Management Interventions for Hip Fracture (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer30_hip-fracture-pain-executive-summary_20110517.pdf
     May 01, 2011 - There were no significant differences between groups for the following adverse effects: cardiac complications

311. Liver-Cancer-Therapy Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/liver-cancer-therapy_research-protocol.pdf
     November 28, 2012 - Patients whose disease is unresectable due to medical comorbidities, such as low hepatic reserve, cardiac

312. Medication-Therapy-Management Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management_research-protocol.pdf
     January 01, 2014 - cholesterol (e.g., total, low-density lipoprotein, and high-density lipoprotein cholesterol), and cardiac

313. Dietary-Supplements Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_executive.pdf
     April 01, 2012 - These included exacerbation of congestive heart failure, number of patients undergoing cardiac procedures … Cardiac patients’ herbal supplement use deserves more careful investigation.

314. Microsoft Word - finbody.doc (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-artery-stenosis_research-2007.pdf
     January 01, 2007 - Among the studies, worse kidney function, higher grade stenosis, various markers of cardiac disease, … Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac

315. Disposition of Comments for CER 163 Appropriate Antibiotics (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antibiotics-respiratory-infection_disposition-comments.pdf
     January 27, 2016 - None of the studies reported using either cardiac CRP (c-CRP) or high sensitivity CRP (hsCRP) assays … levels of this same protein on a mg/l basis for assessment of cardiovascular risk and the presence of cardiac … Comment Response literature largely focuses on the newer hsCRP (mg/L) assays that are used for cardiac

316. VU EPC DBD Protocol_AHRQ comments_revised_clean (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_research-protocol.pdf
     January 30, 2014 - hyperlipidemia • Extrapyramidal effects: parkinsonism, acute dystonia, akathisia, tardive dyskinesia • Cardiac … Extrapyramidal adverse effects: parkinsonism, acute dystonia, akathisia, tardive dyskinesia • Cardiac

317. Methods Guide for Comparative Effectiveness Reviews_Inclusion of Nonrandomized Studies of Interventions in Systematic Reviews of Intervention Effectiveness: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
     September 01, 2022 - a direct association between the IV and the outcome variable.83 9.2.2.3 Example The effect of cardiac … Antidepressant use in pregnancy and the risk of cardiac defects.

318. Methods Guide for Comparative Effectiveness Reviews_Inclusion of Nonrandomized Studies of Interventions in Systematic Reviews of Intervention Effectiveness: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
     September 01, 2022 - a direct association between the IV and the outcome variable.83 9.2.2.3 Example The effect of cardiac … Antidepressant use in pregnancy and the risk of cardiac defects.

319. Hypertension-Pulmonary-Arterial Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypertension-pulmonary-arterial_research-protocol.pdf
     January 30, 2013 - pulmonary artery pressure by 10 mmHg, or to a mean less than 40 mmHg, while maintaining or increasing the cardiac

320. Conducting Quantitative Synthesis when Comparing Medical Interventions: AHRQ and the Effective Health Care Program (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_conductingquantitativesynthesis.pdf
     October 01, 2010 - effects meta-analysis in rare event studies: the rosiglitazone link with myocardial infarction and cardiac